Inotiv Inc – FDA 483
Inotiv, Inc. in West Lafayette, IN, a biopharmaceutics analytical facility, was cited with three observations during an FDA inspection from October 20-24, 2025. The observations primarily concern deficiencies in method validation for insulin aspart, specifically regarding the evaluation of lipemia effects, whole blood stability, and documentation of matrix utilization in validation experiments. These issues indicate a need for improved rigor and documentation in their analytical method validation processes.
- Company
- Inotiv Inc
- Product type
- biologics
ID · 1b736eff-c385-4b5e-b117-46a205c800ef
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.